Seattle Women’s: Health, Research, Gynecology
We offer a unique practice that integrates preventative care and medical treatment in addition to cutting-edge research. Our approach creates a standard of excellence in the specialized care of women.
The office is led by Robin Kroll, MD, a recognized leader in women’s healthcare and research.
Women’s Health
Our team of professionals is committed to providing you with up-to-date, personalized health care. We offer general, preventative, and specialized services for each stage of a woman’s life.
Clinical Research
Clinical research site specializing in women’s health issues. Over the past two decades, Robin Kroll, MD has served as a Principal Investigator for over 200 phase II, III and IV studies.
Help Others in Need
Through our Research with a Mission program, we make anonymous donations to charitable organizations on behalf of each volunteer who participates in a clinical research study.
Participate in Clinical Research!
Browse & Apply for currently enrolling clinical trials in Seattle, Washington. Learn more about your condition, receive access to new treatments, and help your community!
FDA Approves Qbrexza Cloth for the Treatment of Hyperhidrosis
Seattle Women’s is pleased to announce that the FDA has approved a new treatment for axillary hyperhidrosis, also known as excessive underarm sweating. This is a chronic skin condition that affects approximately 10 million people in the United States and causes people to sweat more than what is necessary for normal thermal regulation. The approved
FDA Approves New Migraine Medication
Seattle Women’s is excited to announce that the FDA has approved Aimovig, a new treatment developed specifically for migraine headache prevention. Migraine is a debilitating condition that impacts 38 million patients in the United States. Seattle Women’s conducted one of the pivotal clinical trials involved in the approval process. Aimovig is the first medication in
Intrarosa for Postmenopausal Women Experiencing Pain During Sex Now Available in Pharmacies
Intrarosa (prasterone) was recently FDA approved to treat moderate to severe painful sexual intercourse (dyspareunia) caused by vulvar and vaginal atrophy (VVA). VVA is a common condition affecting up to 50% of postmenopausal women that results from the loss of estrogen during menopause. This causes the walls of the vagina and surrounding tissues to become
